616
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Age-related risk of mortality from bladder cancer in diabetic patients: A 12-year follow-up of a national cohort in Taiwan

, PhD , MD, , &
Pages 371-379 | Received 23 Aug 2008, Published online: 08 Jul 2009

References

  • Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006; 49: 2819–23
  • Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005; 293: 194–202
  • Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007; 16: 83–9
  • Tai TY, Yang CL, Chang CJ, Chang SM, Chen YH, Lin BJ, et al. Epidemiology of diabetes mellitus among adults in Taiwan, R.O.C. J Med Assoc Thai. 1987; 70(Suppl 2)42–8
  • Pan WH, Yeh WT, Chang HY, Hwu CM, Ho LT. Prevalence and awareness of diabetes and mean fasting glucose by age, sex, and region: results from the Nutrition and Health Survey in Taiwan, 1993–1996. Diabet Med. 2003; 20: 182–5
  • Tseng CH, Tseng CP, Chong CK, Huang TP, Song YM, Chou CW, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia. 2006; 49: 1755–60
  • Bureau of Health Promotion, Department of Health, ROC (Taiwan). Final Report on the Survey on Hypertension, Hyperglycemia, and Hyperlipidemia in Taiwan 2002 (in Chinese). Available at: http://www.bhp.doh.gov.tw/health91/pdf/3H/07.pdf, , (accessed 10 December 2008).
  • Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR. Late age (85 years or older) peak incidence of bladder cancer. J Urol. 2008; 179: 1302–5
  • Taiwan Cancer Registry Annual Report. Descriptive Epidemiology of Incidences of Cancers in Taiwan (in Chinese). Available at: http://crs.cph.ntu.edu.tw/crs_c/annual.html, (accessed 10 December 2008).
  • Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care. 2004; 27: 1605–9
  • Tseng CH. Effect of parental hypertension and/or parental diabetes on hypertension in Taiwanese diabetic patients. Eur J Clin Invest. 2007; 37: 870–7
  • Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol. 2001; 153: 411–8
  • Tseng CH. Blackfoot disease and arsenic: A never-ending story. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005; 23: 55–74
  • Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. Arsenic exposure, urinary arsenic speciation and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol. 2005; 206: 299–308
  • Chen, CJ, You, SL, Lin, LH, Hsu, WL, Yang, YW. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32, (Suppl):S66–81.
  • Swerdlow, AJ, dos Santos Silva, I, Reid, A, Qiao, Z, Brewster, DH, Arrundale, J. Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer. 1998;77(Suppl 3):1–54.
  • Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004; 159: 1160–7
  • Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol. 1997; 13: 291–8
  • Chen CH, Shun CT, Huang KH, Huang CY, Tsai YC, Yu HJ, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int. 2007; 100: 281–6
  • Chen CH, Shun CT, Huang KH, Huang CY, Yu HJ, Pu YS. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease. Urology. 2008; 71: 1155–60
  • Tseng CH, Tseng CP, Chong CK, Sheu JJ, Cheng JC. Angiotensin-converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan. Eur J Clin Invest. 2007; 37: 483–91
  • Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res. 2007; 67: 7540–5
  • Chen KS, Lai MK, Huang CC, Chu SH, Leu ML. Urologic cancers in uremic patients. Am J Kidney Dis. 1995; 25: 694–700
  • Feng WW, Wang TN, Chen HC, Ho JC, Ko YC. Malignancies after renal transplantation in southern Taiwan: experience in one centre. BJU Int. 2007; 99: 825–9
  • Chang CH, Yang CM, Yang AH. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer. 2007; 109: 1487–92
  • Kellen E, Zeegers MP, Hond ED, Buntinx F. Blood cadmium may be associated with bladder carcinogenesis: the Belgian case-control study on bladder cancer. Cancer Detect Prev. 2007; 31: 77–82
  • Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH, Hsieh CC. Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology. 1999; 54: 823–8
  • Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, et al. Plasma vitamins E and A and risk of bladder cancer: a case-control analysis. Cancer Causes Control. 2008; 19: 981–92
  • García-Closas R, García-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer. 2007; 43: 1731–40
  • Jiang X, Castelao JE, Groshen S, Cortessis VK, Ross RK, Conti DV, et al. Alcohol consumption and risk of bladder cancer in Los Angeles County. Int J Cancer. 2007; 121: 839–45
  • Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, et al. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2008; 17: 938–44
  • Michaud DS, Kogevinas M, Cantor KP, Villanueva CM, Garcia-Closas M, Rothman N, et al. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect. 2007; 115: 1569–72
  • Murta-Nascimento C, Silverman DT, Kogevinas M, García-Closas M, Rothman N, Tardón A, et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1595–600
  • Ahlgren M, Wohlfahrt J, Olsen LW, Sørensen TI, Melbye M. Birth weight and risk of cancer. Cancer. 2007; 110: 412–9
  • Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol. 2008; 9: 359–66
  • Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 2008; 68: 2530–7
  • McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007; 16: 815–9
  • Yang H, Gu J, Lin X, Grossman HB, Ye Y, Dinney CP, et al. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Clin Cancer Res. 2008; 14: 2236–44
  • Yuan JM, Chan KK, Coetzee GA, Castelao JE, Watson MA, Bell DA, et al. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis. 2008; 29: 1386–93
  • Wang SY, Peng L, Li CP, Li AP, Zhou JW, Zhang ZD, et al. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Int J Urol. 2008; 15: 534–9
  • Koebnick C, Michaud D, Moore SC, Park Y, Hollenbeck A, Ballard-Barbash R, et al. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1214–21
  • Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001; 131: 3109S–3120S
  • Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 1997; 57: 4667–72
  • Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003; 169: 714–7
  • Kravchick S, Gal R, Cytron S, Peled R, Weissman Y, Mukamel E, et al. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol Oncol Res. 2001; 7: 56–9
  • Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X. Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control. 2007; 18: 839–45
  • García-Rodríguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology. 2001; 12: 88–93
  • Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006; 66: 10269–73

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.